Post-earnings recap
Reported
Tue, Aug 6, 2024
EPS actual
$-0.08
EPS est.
$-0.03
EPS surprise
-185.71%
1-day move
-3.60%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
Cytek Biosciences reported a loss per share of $0.08, significantly missing expectations. The stock reacted negatively, declining by 3.6%. The lack of revenue figures and management commentary leaves investors with limited insights into the company's performance and future outlook.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $-0.08 | N/A | -185.71% |
| Revenue | N/A | N/A | N/A |
No transcript is on record for this earnings call, so the analysis is based solely on numerical results.